$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-Q Financial Statement

#000142833618000030 Filed on September 06, 2018

Income Statement

Concept	2018 Q3	2017 Q3
Revenue	$71.07M	$56.88M
YoY Change	24.94%	28.73%
Cost Of Revenue	$24.49M	$21.08M
YoY Change	16.2%	34.84%
Gross Profit	$46.58M	$35.80M
YoY Change	30.09%	25.38%
Gross Profit Margin	65.54%	62.94%
Selling, General & Admin	$15.14M	$11.43M
YoY Change	32.45%	17.33%
% of Gross Profit	32.5%	31.92%
Research & Development	$8.398M	$6.797M
YoY Change	23.55%	36.13%
% of Gross Profit	18.03%	18.98%
Depreciation & Amortization	$800.0K	$600.0K
YoY Change	33.33%	37.3%
% of Gross Profit	1.72%	1.68%
Operating Expenses	$25.01M	$19.31M
YoY Change	29.55%	22.08%
Operating Profit	$21.56M	$16.50M
YoY Change	30.72%	29.48%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$75.00K	-$38.00K
YoY Change	97.37%	2.7%
Pretax Income	$21.49M	$16.46M
YoY Change	30.57%	29.56%
Income Tax	-$1.029M	-$489.0K
% Of Pretax Income	-4.79%	-2.97%
Net Earnings	$22.52M	$16.95M
YoY Change	32.88%	105.83%
Net Earnings / Revenue	31.68%	29.79%
Basic Earnings Per Share	$0.36	$0.28
Diluted Earnings Per Share	$0.36	$0.27
COMMON SHARES
Basic Shares Outstanding	61.88M shares	60.17M shares
Diluted Shares Outstanding	63.40M shares	61.77M shares

Balance Sheet

Concept	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$302.9M	$210.3M
YoY Change	44.03%	40.67%
Cash & Equivalents	$261.8M	$169.7M
Short-Term Investments	$41.10M	$40.60M
Other Short-Term Assets	$11.73M	$8.100M
YoY Change	44.78%	17.39%
Inventory	$163.0K	$339.0K
Prepaid Expenses		$8.078M
Receivables	$24.91M	$20.90M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$339.7M	$239.6M
YoY Change	41.77%	37.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.869M	$6.080M
YoY Change	45.87%	43.03%
Goodwill	$4.651M	$4.651M
YoY Change	0.0%	0.0%
Intangibles	$82.28M	$73.83M
YoY Change	11.45%	12.41%
Long-Term Investments	$100.0K	$206.0K
YoY Change	-51.46%	-26.69%
Other Assets	$18.05M	$1.709M
YoY Change	956.41%	-3.06%
Total Long-Term Assets	$114.9M	$91.32M
YoY Change	25.81%	18.84%
TOTAL ASSETS
Total Short-Term Assets	$339.7M	$239.6M
Total Long-Term Assets	$114.9M	$91.32M
Total Assets	$454.6M	$330.9M
YoY Change	37.37%	32.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.769M	$1.594M
YoY Change	10.98%	-11.49%
Accrued Expenses	$5.577M	$4.829M
YoY Change	15.49%	73.58%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.07M	$12.94M
YoY Change	31.88%	44.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.693M	$2.100M
YoY Change	28.24%	90.91%
Total Long-Term Liabilities	$4.914M	$2.067M
YoY Change	137.74%	-5.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.07M	$12.94M
Total Long-Term Liabilities	$4.914M	$2.067M
Total Liabilities	$21.98M	$15.01M
YoY Change	46.46%	34.91%
SHAREHOLDERS EQUITY
Retained Earnings	$143.0M	$68.87M
YoY Change	107.71%	245.81%
Common Stock	$6.000K	$6.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$432.6M	$315.9M
YoY Change
Total Liabilities & Shareholders Equity	$454.6M	$330.9M
YoY Change	37.37%	32.07%

Cashflow Statement

Concept	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$22.52M	$16.95M
YoY Change	32.88%	105.83%
Depreciation, Depletion And Amortization	$800.0K	$600.0K
YoY Change	33.33%	37.3%
Cash From Operating Activities	$29.90M	$24.20M
YoY Change	23.55%	80.6%
INVESTING ACTIVITIES
Capital Expenditures	-$5.200M	-$12.60M
YoY Change	-58.73%	334.48%
Acquisitions
YoY Change
Other Investing Activities	-$200.0K	-$100.0K
YoY Change	100.0%	0.0%
Cash From Investing Activities	-$5.400M	-$12.80M
YoY Change	-57.81%	326.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	8.300M	3.300M
YoY Change	151.52%	-45.0%
NET CHANGE
Cash From Operating Activities	29.90M	24.20M
Cash From Investing Activities	-5.400M	-12.80M
Cash From Financing Activities	8.300M	3.300M
Net Change In Cash	32.80M	14.70M
YoY Change	123.13%	-10.37%
FREE CASH FLOW
Cash From Operating Activities	$29.90M	$24.20M
Capital Expenditures	-$5.200M	-$12.60M
Free Cash Flow	$35.10M	$36.80M
YoY Change	-4.62%	125.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	hqy	Marketable Securities Unrealized Gain Loss And Other Noncash Income Expense MarketableSecuritiesUnrealizedGainLossAndOtherNoncashIncomeExpense	-27000	USD
	hqy	Marketable Securities Unrealized Gain Loss And Other Noncash Income Expense MarketableSecuritiesUnrealizedGainLossAndOtherNoncashIncomeExpense	-86000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2018-07-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62261227	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY INC
CY2017Q3	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	1082000	USD
	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	2165000	USD
CY2018Q3	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	1478000	USD
	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	2948000	USD
CY2018Q1	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	240269000	USD
CY2018Q3	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	302917000	USD
CY2018Q3	hqy	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.02
	hqy	Exerciseof Stock Options Receivable ExerciseofStockOptionsReceivable	1017000	USD
	hqy	Exerciseof Stock Options Receivable ExerciseofStockOptionsReceivable	135000	USD
CY2017Q3	hqy	Other Expenses Agreements OtherExpensesAgreements	100000	USD
	hqy	Other Expenses Agreements OtherExpensesAgreements	200000	USD
CY2018Q3	hqy	Other Expenses Agreements OtherExpensesAgreements	100000	USD
	hqy	Other Expenses Agreements OtherExpensesAgreements	300000	USD
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	0.10
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited	14.00
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitGranted	50.41
CY2018Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2018Q3	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	44.53
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited	44.53
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitGranted	61.72
CY2018Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	51.44
CY2018Q3	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	61.72
CY2018Q3	hqy	Sharebased Compensation Arrangementby Sharebased Payment Award Additional Shares Availablefor Grants Percentageof Capital Stock Outstanding Percentage SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage	0.03
CY2018	hqy	Tax Cuts And Jobs Actof2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActof2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	500000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2420000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1769000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21602000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
	us-gaap	Payments For Software PaymentsForSoftware	4701000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	3000000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6515000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24906000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5521000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5577000	USD
CY2018Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7415000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8503000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-269000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	261237000	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	289568000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3794000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6803000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5488000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9727000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	208000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	288000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5900000	USD
CY2018Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3500000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7200000	USD
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2018Q1	us-gaap	Assets Assets	369159000	USD
CY2018Q3	us-gaap	Assets Assets	454602000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	265396000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	339713000	USD
CY2018Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40797000	USD
CY2018Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	41109000	USD
CY2018Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	270000	USD
CY2018Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	335000	USD
CY2018Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	626000	USD
CY2018Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	747000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	15631000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15297000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	41109000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	41521000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	25890000	USD
CY2018Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	25812000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	53000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	14000	USD
CY2017Q3	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2000000	USD
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	4200000	USD
CY2018Q3	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2100000	USD
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	4200000	USD
CY2018Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	17600000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139954000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	169721000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199472000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	261808000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	199472000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	261808000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	29767000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	62336000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	240625000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	303329000	USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60825000	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62251000	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60825000	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62251000	shares
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2018Q3	us-gaap	Cost Method Investments CostMethodInvestments	500000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21077000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	42757000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24492000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	50040000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5461000	USD
CY2018Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1038000	USD
CY2018Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1274000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4699000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2351000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2018Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2221000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	600000	USD
	us-gaap	Depreciation Depreciation	1300000	USD
CY2018Q3	us-gaap	Depreciation Depreciation	800000	USD
	us-gaap	Depreciation Depreciation	1700000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7136000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8916000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1014000	USD
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.030
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.041
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.048
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.073
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.388
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.317
CY2018Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.274
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.297
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12549000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9723000	USD
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14400000	USD
CY2018Q3	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.22
CY2018Q3	us-gaap	Equity Method Investments EquityMethodInvestments	100000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	44018000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46010000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	127653000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	128287000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	83635000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	82277000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6234000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12102000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7893000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15400000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	4651000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	4651000	USD
CY2017Q3	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2018Q3	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	35802000	USD
	us-gaap	Gross Profit GrossProfit	69543000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	46575000	USD
	us-gaap	Gross Profit GrossProfit	90931000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16457000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	32294000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21488000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	42027000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-489000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1319000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1029000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3100000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	224000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	368000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3067000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1495000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-837000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3873000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3304000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	900000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	56000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2202000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2826000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-253000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-52000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	611000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	298000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4073000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	6973000	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1592000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1649000	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1517000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1529000	shares
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	83635000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	82277000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	215000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	163000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2100000	USD
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2700000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	22885000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	21983000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	369159000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	454602000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	20490000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	17069000	USD
CY2018Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2395000	USD
CY2018Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4914000	USD
CY2018Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	32000	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-100000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7072000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18469000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17066000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8773000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	39761000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	52640000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	16946000	USD
	us-gaap	Net Income Loss NetIncomeLoss	30975000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	22517000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-75000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-76000	USD
	us-gaap	Payments For Software PaymentsForSoftware	5166000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2161000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	21563000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	42103000	USD
CY2018Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3310000	USD
CY2018Q3	us-gaap	Other Assets Current OtherAssetsCurrent	11727000	USD
CY2018Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4676000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2180000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18054000	USD
	us-gaap	Net Income Loss NetIncomeLoss	45094000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-128000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-76000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	19307000	USD
	us-gaap	Operating Expenses OperatingExpenses	37121000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	25012000	USD
	us-gaap	Operating Expenses OperatingExpenses	48828000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	16495000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	32422000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18027000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-4000	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-30000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	16942000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	30945000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22517000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	45094000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2395000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2693000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-38000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-128000	USD
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	5900000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8869000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6797000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13039000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8398000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16377000	USD
CY2017Q3	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	3100000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3779
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2690000	USD
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7072000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	18469000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15251000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17372000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7836000	USD
CY2018Q3	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	3400000	USD
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	6600000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	85300000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	143045000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	98308000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56879000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	112300000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71067000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	140971000	USD
CY2018Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	500000	USD
CY2018Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	500000	USD
CY2017Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5194000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9815000	USD
CY2018Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7243000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14103000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6803000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9727000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3779
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3784
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3801
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0189
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0207
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0268
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0189
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0252
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2600000.0	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	21.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	30.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	109000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	89000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	102796000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	126579000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3699000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2576000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.83
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.36
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	126579000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	814000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2576000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	26.36
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.86
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	60.07
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	44374000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M24D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M5D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M28D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y1M28D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1103000	shares
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	346274000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	432619000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1300000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1200000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61765000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61604000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63397000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63060000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60173000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59955000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61880000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61531000	shares

Files In Submission

Name	View Source	Status
0001428336-18-000030-index-headers.html	Edgar Link	pending
0001428336-18-000030-index.html	Edgar Link	pending
0001428336-18-000030.txt	Edgar Link	pending
0001428336-18-000030-xbrl.zip	Edgar Link	pending
exhibit101-bloombergemploy.htm	Edgar Link	pending
exhibit102-confidentiality.htm	Edgar Link	pending
exhibit103-amendedandresta.htm	Edgar Link	pending
exhibit311-ceo302x0731.htm	Edgar Link	pending
exhibit312-cfo302x0731.htm	Edgar Link	pending
exhibit321-ceo906x0731.htm	Edgar Link	pending
exhibit322-cfo906x0731.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hqy-20180731.xml	Edgar Link	completed
hqy-20180731.xsd	Edgar Link	pending
hqy-20180731_cal.xml	Edgar Link	unprocessable
hqy-20180731_def.xml	Edgar Link	unprocessable
hqy-20180731_lab.xml	Edgar Link	unprocessable
hqy-20180731_pre.xml	Edgar Link	unprocessable
hqy-2018x7x3110q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2018 Q3 Form 10-Q Financial Statement

#000142833618000030 Filed on September 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2018 Q3 Form 10-Q Financial Statement

#000142833618000030 Filed on September 06, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy